YMYunqing Mei

Yunqing Mei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yunqing Mei has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Xisheng Wang

    Department of Thoracic Cardiovascular Surgery of Tongji Hospital of Tongji University

    6 shared publications
  • Jing Feng

    Department of Thoracic Cardiovascular Surgery, Tongji Hospital of Tongji University, Shanghai, China

    5 shared publications
  • Jianzhi Cai

    Department of Thoracic Cardiovascular Surgery, Tongji Hospital of Tongji University, Shanghai, China

    4 shared publications
  • Qiang Ji

    Department of Thoracic Cardiovascular Surgery, Tongji Hospital of Tongji University, Shanghai, China

    4 shared publications
  • Qiang Ji

    Department of Thoracic Cardiovascular Surgery of Tongji Hospital of Tongji University

    4 shared publications
  • Shiliang Xie

    Department of Thoracic Cardiovascular Surgery, Tongji Hospital of Tongji University, Shanghai, China

    4 shared publications

Latest Publications

  • Open Access

    Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits

    by Xisheng Wang, Yunqing Mei, Qiang Ji, Jing Feng, Jianzhi Cai, Shiliang Xie

    The excess proliferation of vascular smooth muscle cells (VSMCs) and the development of intimal hyperplasia is a hallmark of vein graft failure. This study aimed to verify that a single intraoperative transfection of early growth response gene-1 (Egr-1) decoy oligonucleotide (ODN) can suppress vein graft proliferation of VSMCs and intimal hyperplasia. In a rabbit model, jugular veins were treated with Egr-1 decoy ODN, scrambled decoy ODN, Fugene6, or were left untreated, then grafted to the carotid artery. The vein graft samples were obtained 48 h, 1, 2 or 3 weeks after surgery. The thickness of the intima and intima/media ratio in the grafts was analysed by haematoxylin-eosin (HE) staining. The expression of the Egr-1 decoy ODN transfected in the vein was analysed using fluorescent microscopy. Egr-1 mRNA was measured using reverse transcription-polymerase chain reaction. The expression of Egr-1 protein was analysed by Western blot and immunohistochemistry. Transfection efficiency of the ODN was confirmed by 4′, 6-diamidino-2-phenylindole staining. In the grafts treated with Egr-1 decoy ODN, our study achieved statistically significant inhibition of intimal hyperplasia by ∼58% at 3 weeks. Transfection of Egr-1 decoy ODNs decreased the protein expression of Egr-1 and Egr-1 mRNA. We confirmed that gene therapy using in vivo transfection of an Egr-1 decoy ODN significantly inhibits proliferation of VSMC and intimal hyperplasia of vein grafts in a rabbit model.


  • Open Access

    Early results after surgical treatment of left Ventricular Aneurysm

    by Xisheng Wang, Xuezhi He, Yunqing Mei, Qiang Ji, Jing Feng, Jianzhi Cai, Yifeng Sun, Shiliang Xie

    Left ventricular aneurysm (LVA) is a serious complication of myocardial infarction and reduces the chances of survival. Controversy still exists regarding the optimal surgical technique for LVA repair. We analyze the efficacy of two techniques, linear vs. endoventricular circular patch plasty, for repair of LVA and the efficacy of surgical ventricular restoration (SVR) on beating heart.


  • Short-term effects of double-layer autologous vein graft on restraint of excessive distension and alleviation of neointimal hyperplasia in a porcine saphenous vein graft model

    by Qiang Ji, Yunqing Mei, Xisheng Wang, Jing Feng, Jianzhi Cai, Yifeng Sun, Wusha Dewei, Chunping Wang, Liangjie Chi

    Although the use of external vein graft support seems a promising approach to prevent neointimal hyperplasia and wall thickening in vein grafts, its extensive clinical application still has a long way to go. The aim of this study was to evaluate short-term effects of self-designed double-layer autologous saphenous vein graft on restraining excessive distension of vein graft and alleviating neointimal hyperplasia in a porcine model. Left and right hind femoral arteries of 24 white pigs were randomly divided into an experimental group (double-layer vein graft) and a control group (single-layer vein graft). After 1 h of implantation, then 1, 2, and 4 weeks later, the mean inner diameter of the vein grafts in the experimental group measured by Doppler-ultrasound was 2.7 ± 0.1, 2.8 ± 0.1, 2.9 ± 0.1, and 3.1 ± 0.1 mm, respectively; mean peak blood flow velocity measured by Doppler-ultrasound was 96.7 ± 12.8, 93.7 ± 11.5, 89.4 ± 9.6 and 84.6 ± 10.1 cm/s, respectively, while the mean neointimal thicknesses were 47.1 ± 7.7, 93.7 ± 15.1, and 177.4 ± 25.5 μm at 1, 2 and 4 weeks, respectively. As compared to the control group, inner diameter and neointimal thickness of vein grafts in the experimental group were significantly lower, while mean peak blood flow velocity was significantly higher at 1, 2, and 4 weeks after implantation. The proliferation index in the experimental group was also significantly lower within 4 weeks after implantation. The self-designed double-layer autologous saphenous vein graft restrains early excessive distension of vein graft and alleviates early neointimal hyperplasia.


  • Timing of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery

    by Qiang Ji, Yunqing Mei, Xisheng Wang, Jing Feng, Jianzhi Cai, Yongxin Zhou, Yifeng Sun, Shiliang Xie, Dayi Hu

    The purpose was to study optimum timing of continuous veno-venous hemodialysis (CVVHD) for acute renal failure (ARF) after cardiac surgery. CVVHD was performed in two groups [elapsed time between urine output (UO) 12 h in group B] with a total of 58 adult patients. Survivors in groups A and B were entered into groups A1 and Bl, respectively. Compared to group A, the acute physiology and chronic health evaluation III score, peak values of urea and creatinine before CVVHD, major complications, period of ICU and hospitalization were significantly higher in group B. In-hospital mortality in group B was significantly higher than that in group A (37.5 vs. 8.8%, p = 0.02). Kaplan-Meier curves confirmed significantly better postoperative survival in group A (χ 2 = 6.966, p = 0.008). Time elapse from UO < 0.5 ml/kg/h until dialysis among the survivors was significantly lower than that among the dead (12.0 ± 6.2 vs. 20.8 ± 9.1 h, p = 0.0002). Additionally, duration of dialysis, length of ICU stay, duration of ventilator support and time elapse from dialysis until UO > 1 ml/kg/h were significantly higher in group B1 as compared to those in group A1. All of them correlated positively with the time elapse from UO < 0.5 ml/kg/h until dialysis. Early beginning of CVVHD is extremely important.


  • Open Access

    Combination of Irbesartan and Amiodarone to Maintain Sinus Rhythm in Patients With Persistent Atrial Fibrillation After Rheumatic Valve Replacement

    by Qiang Ji, Yunqing Mei, Xisheng Wang, Jing Feng, Dewei Wusha, Jianzhi Cai, Yifeng Sun, Shiliang Xie

    Background: Atrial fibrillation (AF) after rheumatic valve replacement is the most common arrhythmic complication. Previous studies reported angiotensin-II receptor blocker can prevent AF. This study aimed to assess the effect of a combination of irbesartan and amiodarone on the maintenance of sinus rhythm after cardioversion of AF in patients with post-rheumatic valve replacement in a randomized, controlled trial. Methods and Results: Eighty-five consecutive patients undergoing rheumatic valve surgery were enrolled and randomly assigned to an irbesartan plus amiodarone (irbesartan 150 mg/d, n=43) or an amiodarone group (n=42) starting 10 days before scheduled electrical cardioversion. The primary end-point was recurrence of AF. Pharmacological conversion was documented in 7 patients, and electrical conversion in 68 patients (87.2%). A higher rate of maintenance of sinus rhythm (69.8% vs 40.5%, P=0.01) and a better AF-free survival (χ2=7.466, P=0.006) were observed in the irbesartan plus amiodarone group compared to the amiodarone group during the 1-year follow-up period. Cox regression showed that use of irbesartan was an independent factor associated with the maintenance of sinus rhythm after cardioversion (OR=0.43, P=0.018), whereas increased left atrium diameter was associated with increased risk (OR=1.54, P=0.005). Conclusions: In patients with post-rheumatic valve replacement, the combination of amiodarone and irbesartan demonstrated a lower rate of AF recurrence after cardioversion than amiodarone alone, which might be due to preventing the atrial remodeling. (Circ J 2010; 74: 1873 - 1879)


  • A giant cyst-like mass: an unusual morphous of left atrial myxoma

    by Xi-Sheng Wang, Yun-Qing Mei, Da-Yi Hu, Da-Wen Li, Qiang Ji


  • Transcatheter Closure of Adult Patent Ductus Arteriosus with Severe Pulmonary Hypertension

    by Qiang Ji, Jing Feng, Yunqing Mei, Xisheng Wang, Jiangzhi Cai, Yifeng Sun, Yongxin Zhou, Dawen Li, Yongwu Wang

    Hypertension Research, official publication of the Japanese Society of Hypertension, publishes papers reporting original clinical and experimental research in the field of hypertension and related cardiovascular diseases.